JP Morgan cuts Xylem price target to $118, keeps Neutral rating
- JP Morgan lowers Xylem price target from $137 to $118
- Analyst Mark Strouse maintains Neutral rating on the stock
- Price target reduction amounts to $19 per share

*this image is generated using AI for illustrative purposes only.
JP Morgan analyst Mark Strouse has lowered the price target for Xylem Inc from $137 to $118 while maintaining a Neutral rating on the stock.
The revision reduces the implied upside potential for investors by $19 per share compared to the previous target. The firm continues to hold a Neutral stance, indicating no immediate recommendation to buy or sell the shares at current levels.
What specific macroeconomic or operational factors drove the $19 reduction in Xylem's price target?
How are other major financial institutions adjusting their price targets for Xylem in response to this revision?
Will the lowered target influence institutional investor sentiment and trading volume for Xylem shares in the near term?

































